A minority of individuals infected with the parasite Schistosoma mansoni develops hepatic fibrosis. HLA studies in Egypt and a candidate gene search in a Sudanese population indicate that the host's genetics contribute to disease susceptibility. In an Egyptian community, 32.7% of individuals 11 years and older had significant fibrosis by WHO ultrasound criteria. Linkage to 10 candidate genes was tested using 89 affected sibling pairs from 40 pedigrees in this community. The candidates included genes that initiate fibrosis, participate in collagen synthesis, or control collagen degradation. Two to four single-nucleotide polymorphisms (SNPs) were genotyped per locus, and 188 individuals were genotyped at 48 markers. Model-free modified Haseman-Elston analysis identified linkage to a SNP in the interferon gamma receptor locus (P ¼ 0.000001). There was also weak evidence for linkage to the interleukin 13-4 region and tissue growth factor beta 1.
Introduction
Only 5 -10% of individuals infected with the blood fluke Schistosoma mansoni will develop hepatic fibrosis, and in population-based studies, intensity of infection does not correlate well with the presence of fibrosis by ultrasound. Thus, infection in and of itself is not equivalent to disease. This observation is central to understanding the distribution of many infectious diseases. For schistosomal fibrosis, different geographic regions display great variation in the severity of disease that is not well explained by the intensity or prevalence of infection alone. 1 This variability is also found between individuals living in the same endemic area. There is increasing evidence that, among other factors, host genetic differences account for a portion of this variability. 2 Dessein et al 2 conducted a search for four candidate genes related to S. mansoni induced hepatic fibrosis and found linkage in a region near the interferon gamma receptor 1 (IFNGR1) gene. However, this study was strongly biased in favor of examining areas directly related to immune response and not the final pathway of collagen deposition and maturation. In addition, even for genes that influence immune responses, additional good candidates exist. The purpose of this work was to search for genes linked to hepatic fibrosis from among 11 candidates and in a different population than the previous study. This study extends previous observations by reexamining linkage between schistosomal fibrosis and the already identified IFNGR1 region, as well as important candidates not assessed previously. We therefore chose to investigate genes regulating immunologic responses (IL10, IL13 -IL4, IFNGR1, TGFb1), genes regulating collagen production and stability (CTGF, Col1a1, Col3a1, LOX) and genes responsible for collagen degradation (MMP1, MMP2, TIMP1) Table 1 . In addition, this work focused on multiple nuclear families in a population not previously studied.
Methods, subjects and materials
Population Individuals over 11 years of age from a community in Kafr el Sheikh governorate, Nile Delta, Egypt were examined by portable ultrasound for evidence of schistosomal hepatic fibrosis. This region has traditionally had the country's highest prevalence of S. mansoni infection. 3 Approximately 70% of those eligible in the central community and some individuals from the nearby hamlets (ezbas) were surveyed (n ¼ 2051). Blood was collected from first-degree relatives in families with more than one sibling with grade C or higher fibrosis (WHO criteria 4 ). Prior to the study, there
were three consecutive years of mass treatment for school children in this community followed by three more years of targeted chemotherapy for infected adults and children. This study was performed in accordance with the ethical guidelines for human research set forth in the Declaration of Helsinki, under a protocol approved by the Human Investigation Review Boards of University Hospitals of Cleveland, OH, USA and Cairo University, Egypt. All participants gave free and informed consent for use of their blood for serologic, biochemical and genetic studies.
Phenotype determination and construction
The diagnosis and grading of schistosomal hepatic fibrosis was based on WHO criteria established in the year 2000 and modified for this study. 4, 5 The standard consists of a qualitative determination of the overall condition of the liver graded according to predetermined patterns (image pattern). The standard also includes a quantitative measurement of the two-wall thickness of the first intrahepatic branch point of the portal vein (PBWT) and the diameter of the main portal vein (PVD). Magnification was used to increase accuracy of these measurements. The images were obtained by two Egyptian ultrasonographers and interpreted by a third radiologist not involved in the Egyptian study. The radiologists' agreement on image pattern was 84% (k statistic ¼ 0.534 where a statistic 40.40 is considered good concurrence). The qualitative score or 'image pattern' was highly correlated with both quantitative measurements, 5, 6 and the ultrasound examination has been validated histologically for sensitivity and specificity for hepatic fibrosis due to S. mansoni.
7,8
Schistosomal fibrosis was modeled as both binary and quantitative traits based on ultrasound image pattern, PBWT and PVD. The binary phenotype was further defined as simple or severe fibrosis in order to allow comparisons with the only other linkage study for this condition. Simple fibrosis was defined as any image pattern whose severity was Z grade C. Severe fibrosis was defined Z as grade D. The severe fibrosis definition also included those with grade C patterns where the portal vein diameter was 42 SD from the mean of those with normal image patterns (ie 414.0 mm).
Quantitative traits consisted of the image pattern, the PBWT and PVD. The image pattern was converted to a quantitative scale by assigning each letter value (A -F) to a sequential integer (0 -5). This scaling of the image pattern is linearly related to the continuous measurements PBWT and PVD. 6 Probands were considered affected if their image pattern was grade C or more severe. Families entered the study based on having at least two affected siblings. Although hepatitis B and C are common in this community, the hepatitis serology is known not to be associated with schistosomal fibrosis and was not, therefore, considered as a covariate in the analysis. 6 Blood, plasma and DNA In total, 10 ml of blood was collected from those with significant schistosomal fibrosis and their firstdegree relatives. Plasma and buffy coat were separated and frozen at À201C. DNA was isolated from the buffy coat using the Blood and Cell Culture Kit from Qiagen (Qiagen Inc., Valencia, CA, USA) according to the manufacturer's recommendation. Each sample was measured for DNA content by UV absorption spectrophotometry.
Candidate gene and marker selection
The candidates single-nucleotide polymorphisms (SNPs) were selected based on the weight of published evidence, their allele frequency, if known, and relative distance from other markers. For each gene, 4 -6 SNPs were selected for genotyping. TNFa polymorphisms were excluded, due to difficulty identifying unique regions in the genome for primer design near the desired SNPs. Further, several studies have indicated no linkage 2 or association 9 with this gene and schistosomal fibrosis (S. mansoni and S. japonicum infection, respectively). Markers were selected within the following genes: interleukin 10 (IL10), interleukin 13 and 4 (IL13 -IL4), IFNGR1, tissue growth factor beta 1 (TGFb1), connective tissue growth factor (CTGF), type I collagen (Col1a1), type III collagen (Col3a1), lysyl oxidase (LOX), metalloproteinase 1 (MMP1), metalloproteinase 2 (MMP2), and tissue inhibitor of metalloproteinase 1 (TIMP1). DNAprint Genomics (Sarasota, FL, USA) performed all of the genotyping using the SNP-It (Orchid Biosciences, Princeton, NJ, USA) ultrahigh throughput single-nucleotide extension method. 10 The program Genehunter (version 2.1) 11 was used to determine the information content of the markers.
Model-free linkage analysis
Linkage to schistosomal hepatic fibrosis was analyzed using the model-free, modified Haseman -Elston method 12 implemented in the program Sibpal (Statistical Analysis for 
Results
Pedigree structure A total of 40 pedigrees were collected that contained multiple affected siblings and whose members provided a blood sample ( 
Phenotype distribution
For the simple definition of fibrosis, the finding of C grade pathology was sufficient for identifying affecteds. Under the severe fibrosis phenotype, only 14% (7/48) of individuals with the C pattern were considered affected (Table 3) .
Of those who fulfilled the simple criteria of fibrosis, 58% were considered affected under the more severe definition.
In the whole population, the prevalence of fibrosis under the simple definition was 36.8% and using severe fibrosis definition was 21.6%. There was no difference in age using the simple or severe fibrosis phenotypes (39. 
Genotyping
A total of 186 individuals were genotyped in 40 pedigrees at 48 SNP markers targeted to 11 genes. Of the 48 markers used for typing, 35 (72.9%) amplified successfully and were polymorphic (Table 4) . Of these, 20% had minor allele frequencies o0.05 and correspondingly low heterozygosities and information content. The mean single point information content for the 35 polymorphic alleles was 0.1570.09. For the X-linked TIMP1, all markers for this gene either failed to amplify or were nearly monoallelic, so, linkage to this gene could not be further assessed.
Four markers had an individual failure rate in excess of 80% and nine were monomorphic. All individual DNA samples could be typed at most loci, so that DNA quality was not considered a factor in typing failures. The failures are likely to represent polymorphisms in the primer target sequence on the template. The dbSNP site of Genebank (www.ncbi.nlm.nih.gov/SNP/) provided allele frequencies for 62.0% of the selected SNPs. The expected crude average heterozygosity of successfully genotyped SNPs based on the dbSNP database was 29.6%, compared to 27.4% observed for these same SNPs in the Shamarka population. Single point analysis There were 11 candidate genes tested for linkage. The markers within each gene were not considered independent; therefore, the Bonferroni correction was applied for testing multiple genes, and a P-value of 0.0045 (a ¼ 0.05/ 11) was the chosen level of significance. With single point analysis the most significant P-value, 0.0000013, was obtained for the IFNGR1 marker rs1327475 (chromosome 6) using the ultrasound pattern as the quantitative trait ( Figure 1 ). For the binary trait definition, there was significant evidence for linkage, using either the simple or the severe fibrosis phenotype (Po0.001 and 0.004, respectively). Two additional markers in other genes produced significant P-values only when the ultrasound pattern was used. For the marker rs2243250 in the IL4 promoter (chromosome 5), the P-value was 0.004. Although the P-values were higher than the limit set by Bonferroni correction, both TGFb1 markers (chromosome 14) had small P-values near the corrected level of significance. Other markers within the IFNGR1 gene or the IL13 -IL4 gene clusters did not produce noticeably smaller P-values than markers in other regions.
Multipoint analysis
Five loci or regions (Col3a1, IL13 -IL4, IFNGR1, Col1a1 and TGFb1) were found to have P-values o0.05 (Figure 2 ). Only the marker rs1056854 in the TGFb1 gene had a score that was significant after correction for multiple tests, and only when the ultrasound pattern was used as the trait. Only the IFNGR1 had multipoint P-values of o0.05 for more than one phenotype. Not surprisingly, three of the four SNPs across the IFGR1 gene are in strong linkage disequilibrium (rs608914, rs1327474, rs1327475) and thus may not contribute much information to the multipoint analysis.
Effect of covariates
Neither age, sex, nor PBWT were found to affect linkage based on either the simple or severe fibrosis phenotype. Lodpal analysis did, however, show a significant effect of PVD for the IFNGR1 marker rs1327475 when the severe phenotype was used.
Discussion
In this study we used SNP markers to search for evidence of linkage to 11 candidate genes in a population with Egypt's highest prevalence of infection. We found evidence for linkage of schistosomal hepatic fibrosis to a polymorphism in the INFGR1 gene and suggestive evidence for linkage to a locus in the IL13 -IL4 region and TGFb1. The rs1327475 marker of IFNGR1 produced the most significant P-value (0.0000013) in model-free single point analysis. This was a Figure 1 Converted P-value for single point modified Haseman -Elston linkage analysis. ÀLog 10 (P-value) for linkage to schistosomal fibrosis were plotted for each marker and for each definition of the phenotype. Significant linkage is indicated by a ÀLog 10 (P-value) ¼ 2.34, that is, P-value of 0.0046 was considered significant after correction for multiple tests. Simple -simple definition of fibrosis used for phenotype; Severe -severe definition of fibrosis used for phenotype; PATTERN -ultrasound image pattern; PBWT -portal branch wall thickness; PVD -portal vein diameter. P-values available in supplemental Table 5 .
significant value even after correction for multiple tests. In addition, this marker consistently showed significance under several phenotype definitions. Linkage to this gene is further supported by studies with IFNGR1 null mice that indicate this is a fibrosis-prone phenotype. Finally, the only other linkage study for this disease also identified region of the IFNGR1 gene as linked to the development of severe schistosomal fibrosis.
2 g interferon has long been associated with a protective affect against the development of fibrosis in S. mansoni infection 15 as well as liver cells undergoing other forms of damage.
16,17
The cytokine's receptor has only recently been the focus of study due primarily to the availability of IFNGR1 null mutant mice. Rezende et al 18 confirmed the lack of any effect on resistance to infection in these mice, but convincingly demonstrated both smaller granuloma size and rapid development of intense fibrosis in IFNGR1 null animals. In these animals, maturation of monocytes to macrophages failed or was delayed, 19 and migration of B and CD4 þ cells into the granulomas was also delayed. The numbers of connective tissue cells and their in vitro proliferation, however, were increased.
IFNGR1 null mice also develop more hepatic fibrosis in response to intracellular infection with the murine gammaherpes virus. 20 This indicates that polymorphisms in this gene may be associated with a generalized susceptibility to hepatic fibrosis. This is particularly intriguing, given the more severe pathology found in this Egyptian population for both schistosomiasis and hepatitis C compared to a Kenyan population where both infections result in much more benign disease with respect to the liver. 1 In humans, severe defects in IFNGR1 are probably selected against and are therefore rare. 21, 22 There have been genetic studies, however, that associated common polymorphisms (allele frequency B0.5) in the IFNGR1 gene to presumably milder defects such as increased susceptibility to cerebral malaria or Helicobacter pylori infection. 23, 24 In both cases, morbidity was associated with a promoter polymorphism (À56 C/T, or rs2234711). Reporter gene constructs with the 'C' mutation were found to produce lower levels of expression and perhaps explain differences in morbidity on this basis. 25 Unfortunately, this effect had not been reported at the time of this analysis and this marker was not included. The marker rs1327475, Figure 2 Converted P-value for multipoint modified Haseman -Elston linkage analysis. ÀLog 10 (P-value) for linkage to schistosomal fibrosis were plotted for each marker and for each definition of the phenotype. Significant linkage is indicated by a ÀLog 10 (P-value) ¼ 2.34, that is, P-value of 0.0046 was considered significant after correction for multiple tests. Simple -simple definition of fibrosis used for phenotype; Severe -severe definition of fibrosis used for phenotype; PATTERN -ultrasound image pattern; PBWT -portal branch wall thickness; PVD -portal vein diameter. P-values available in supplemental Table 6 .
however, is 4000 nucleotides downstream of rs2234711 and may be in linkage disequilibrium with this locus. The strength of the evidence needs to be qualified somewhat since only one marker in the IFNGR1 gene showed significance and since multipoint analysis failed to increase significance at these markers. This may be due to the use of closely spaced SNP markers. In association studies, linkage disequilibrium between adjacent SNPs does not consistently fall or rise with distance when the interval is short (5 -32 kb) . 26 -28 Saunders et al 29 also observed a wide variation in the strength of association between individual SNPs and disease even in simulated data. This is often explained by varying or low allele frequencies, but even some common polymorphisms near a functional locus may show no association. Linkage studies rely on information from recombination, but over short distances, the effects of mutation, genetic drift, and population admixture outweigh those of recombination. 30 One of the few studies to use SNPs for linkage analysis also found more evidence for linkage using single point analysis than multipoint linkage. 31 Since linkage analysis relies on recombination and currently available methods assume linkage equilibrium, a failure to increase significance in multipoint analysis may be in the nature of linkage studies with closely positioned SNP markers. 32 -34 For closely spaced markers it appears that more than four good quality SNPs should be used for linkage or association studies. Two additional genes had markers that were significant after correction (IL13 -IL4) or had scores near this level (TGFb1). The IL13 -IL4 region produced a significant Lod score only for one marker, and only when the ultrasound pattern was used as the trait. Although the TGFb1 markers were only near the level of significance, both markers that could be typed for this locus had similarly low P-values. This suggests they may have an effect on the phenotype, but are limited to a few families or are less influential than the INFGR1.
In addition to locus heterogeneity, demographic or environmental factors may affect the power to detect linkage. Within the population, fibrosis varied significantly by age and sex. The loci that demonstrated significance with single point analysis were assessed with respect to age, sex, PBWT and PVD to determine if these covariates influenced linkage. For the simple fibrosis phenotype, none of these was found to be significant. The age difference between sibs appears to be sufficiently small that it did not contribute much information for linkage, and the difference in rates of fibrosis by sex does not have a genetic origin at these loci. It is likely that the lower participation of women in agriculture and exposure to infection in this community accounts for much of the sex differences in fibrosis.
In order to permit comparisons with other studies, two definitions for fibrosis were employed. Under the latest WHO guidelines, the C ultrasound pattern of pathology is specific for schistosomal fibrosis, and so was used as the only ultrasound criterion for collecting families in Egypt. The only other linkage study for this disease to date defined fibrosis by the equivalent of the more severe D pattern and also included those with C pattern and PVD dilatation. Stratification by this severe phenotype only weakened the evidence for linkage by reducing the sample size. This suggests that the simple fibrosis phenotype is likely to have the same genetic basis as the more severe definition and uses more of the available information from the population.
The identification of genes linked to hepatic fibrosis is a starting point for investigation. This work in addition to providing strong support for IFNGR1 as a major gene locus in schistosomal fibrosis, suggests that genes in the region of IL13 -IL4 and TGFb1 are also linked. A limitation of this or any candidate gene approach is that out of thousands of genes, up to half of which are of unknown function, enough information is available that less than a dozen can be selected for testing. Schistosomal hepatic fibrosis still awaits evaluation with a genome-wide scan, the best available method to broadly survey for additional loci. It would also provide perspective on the relative importance of the loci identified here.
